CPVT and Complete Atrio-Ventricular Block: The Flipside of the Same Coin

CPVT and Complete Atrio-Ventricular Block: The Flipside of the Same Coin

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare electrical genetic disease characterized by ventricular polymorphic tachycardia and/or bidirectional ventricular tachycardia induced by the release of catecholamines caused by intense physical or emotional stress in structurally...

Full description

Bibliographic Details
Main Authors:	Mattia Petrungaro, Antonio Scarà, Alessio Borrelli, Luigi Sciarra
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Journal of Cardiovascular Development and Disease
Subjects:	CPVT TVNS Ryr2 sudden cardiac death catecholaminergic polymorphic ventricular tachycardia
Online Access:	https://www.mdpi.com/2308-3425/10/3/97

Similar Items

Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review
by: Justin Leung, et al.
Published: (2022-07-01)

A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the <em>RYR2</em> Gene
by: Małgorzata Stępień-Wojno, et al.
Published: (2020-06-01)

Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases
by: Norbert Szentandrássy, et al.
Published: (2022-04-01)

Catecholaminergic polymorphic ventricular tachycardia: An exciting new era
by: Shashank P Behere, et al.
Published: (2016-01-01)

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations
by: Xiaohui Kong, et al.
Published: (2023-06-01)

Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report
by: L. K. Seidlmayer, et al.
Published: (2018-10-01)

Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four‐generation Canadian family
by: Matthew Tung, et al.
Published: (2020-04-01)

Flipping syncope: The case of an adolescent athlete with syncopal episodes ultimately diagnosed with catecholaminergic polymorphic ventricular tachycardia
by: Collin C. Kramer, et al.
Published: (2020-08-01)

Bidirectional Ventricular Tachycardia: A Hallmark of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Dr. Francisco Femenia, MD, et al.
Published: (2012-03-01)

Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease
by: Stjepan Jurisic, et al.
Published: (2023-12-01)

Choking-induced cardiac arrest unmasks a diagnosis of catecholaminergic polymorphic ventricular tachycardia
by: Thomas M. Roston, MD, et al.
Published: (2015-11-01)

Catecholaminergic polymorphic ventricular tachycardia in 2012
by: Christian van der Werf, et al.
Published: (2011-12-01)

A Type 2 Ryanodine Receptor Variant in the Helical Domain 2 Associated with an Impairment of the Adrenergic Response
by: Malorie Blancard, et al.
Published: (2021-06-01)

Flecainide Paradoxically Activates Cardiac Ryanodine Receptor Channels under Low Activity Conditions: A Potential Pro-Arrhythmic Action
by: Samantha C. Salvage, et al.
Published: (2021-08-01)

CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature
by: Giannis G. Baltogiannis, et al.
Published: (2019-07-01)

Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
by: Angela F. Dulhunty
Published: (2022-02-01)

Taquicardia ventricular polimórfica catecolaminérgica Catecholaminergic polymorphic ventricular tachycardia
by: Marleny Cruz Cardentey
Published: (2012-06-01)

Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
by: Henrik Eckert, et al.
Published: (2022-03-01)

Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist
by: Dania Kallas, et al.
Published: (2021-08-01)

Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
by: Hyun Seok Hwang, et al.
Published: (2019-08-01)

Arrhythmogenic Mechanism of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Nian Liu, MD, et al.
Published: (2006-01-01)

Clinical Characteristics, Genetic Basis and Healthcare Resource Utilisation and Costs in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia: A Retrospective Cohort Study
by: Cheuk To Chung, et al.
Published: (2022-08-01)

Diagnosis of catecholaminergic polymorphic ventricular tachycardia during late adulthood due to a rare genetic variant in RYR2: a case report
by: Laura García-Cano, et al.
Published: (2021-08-01)

Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling
by: Claire Hopton, et al.
Published: (2022-04-01)

Bidirectional Ventricular Tachycardia: Challenges and Solutions
by: Almarzuqi A, et al.
Published: (2022-06-01)

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes
by: Atara Novak, et al.
Published: (2012-07-01)

Advances in the Molecular Genetics of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Junxia Song, et al.
Published: (2021-08-01)

Alternans in genetically modified Langendorff-perfused murine hearts modeling catecholaminergic polymorphic ventricular tachycardia
by: Ian N Sabir, et al.
Published: (2010-10-01)

Every face tells a story-unravelling a case of bidirectional ventricular tachycardia
by: Sakshi Sachdeva, et al.
Published: (2020-09-01)

A case of catecholaminergic polymorphic ventricular tachycardia masquerading as an intractable seizure
by: Reza Shabanian, et al.
Published: (2020-01-01)

An Optogenetic Arrhythmia Model—Insertion of Several Catecholaminergic Polymorphic Ventricular Tachycardia Mutations Into Caenorhabditis elegans UNC-68 Disturbs Calstabin-Mediated Stabilization of the Ryanodine Receptor Homolog
by: Marcial Alexander Engel, et al.
Published: (2022-03-01)

Assessment of disease-associated missense variants in RYR2 on transcript splicing
by: Damilola Olubando, et al.
Published: (2020-06-01)

Thoracoscopic Left Cardiac Sympathetic Denervation for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia and Recurrent Implantable Cardioverter-Defibrillator Shocks
by: Woo-Sik Yu, et al.
Published: (2015-06-01)

Defective ryanodine receptor N-terminus inter-subunit interaction is a common mechanism in neuromuscular and cardiac disorders
by: Yadan Zhang, et al.
Published: (2022-10-01)

Electrophysiological Characteristics and Ablation Outcomes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
by: Lishui Shen, et al.
Published: (2023-12-01)

Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia
by: Yu Yan, et al.
Published: (2023-12-01)

Energy exergy and economic evaluation of a CCHP configuration powered by CPVT collectors dynamically
by: Seyed Mohammadreza Esmaeili, et al.
Published: (2023-12-01)

Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies
by: Abhinav Aggarwal, et al.
Published: (2024-03-01)

<i>CASQ2</i>: clinical and genetic insights into catecholaminergic polymorphic ventricular tachycardia across three families
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2023-08-01)

Techno-Economic Assessment of CPVT Spectral Splitting Technology: A Case Study on Saudi Arabia
by: Cesar Lucio, et al.
Published: (2023-07-01)